Mostrar el registro sencillo del ítem

dc.contributor.author
Orellano, Pablo Wenceslao  
dc.contributor.author
Reynoso, Julieta Itati  
dc.contributor.author
Stahl, Hans Christian  
dc.contributor.author
Salomón, Oscar Daniel  
dc.date.available
2020-05-18T20:13:35Z  
dc.date.issued
2016-01  
dc.identifier.citation
Orellano, Pablo Wenceslao; Reynoso, Julieta Itati; Stahl, Hans Christian; Salomón, Oscar Daniel; Cost-utility analysis of dengue vaccination in a country with heterogeneous risk of dengue transmission; Elsevier; Vaccine; 34; 5; 1-2016; 616-621  
dc.identifier.issn
0264-410X  
dc.identifier.uri
http://hdl.handle.net/11336/105411  
dc.description.abstract
BACKGROUND:Dengue is one of the most important vector-borne diseases worldwide, and annually, nearly 390 million people are infected and 500,000 patients are hospitalized for severe dengue. Argentina has great variability in the risk of dengue transmission due to eco-climatic reasons. Currently no vaccines are available for dengue even though several vaccines are under development.OBJECTIVE:The aim of this study was to estimate the cost-effectiveness of a dengue vaccine in a country with heterogeneous risk of dengue transmission like Argentina.METHODS:The analysis was carried out from a societal perspective using a Markov model that included both vaccine and disease parameters. Utility was measured as disability adjusted life years (DALYs) averted, and the incremental cost-effectiveness ratio (ICER) of the vaccination was expressed in 2014 American dollars (US$) per DALY averted. One-way and probabilistic sensitivity analyses were performed to evaluate uncertainty in model outcomes, and a threshold analysis was conducted to estimate the highest possible price of the vaccine.RESULTS:The ICER of the vaccination program was found to be US$ 5714 per DALY averted. This value is lower than 3 times the per capita GDP of Argentina (US$ 38,619 in 2014); 54.9% of the simulations were below this value. If a vaccination program would be implemented the maximum vaccine price per dose has to be US$1.49 for a vaccination at national level or US$28.72 for a targeted vaccination in high transmission areas.CONCLUSIONS:These results demonstrate that vaccination against dengue would be cost-effective in Argentina, especially if carried out in predetermined regions at high risk of dengue transmission. However, these results should be interpreted with caution because the probabilistic sensitivity analysis showed that there was considerable uncertainty around the ICER value. The influence of variations in vaccine efficacy, cost and other important parameters are discussed in the text.  
dc.format
application/pdf  
dc.language.iso
eng  
dc.publisher
Elsevier  
dc.rights
info:eu-repo/semantics/openAccess  
dc.rights.uri
https://creativecommons.org/licenses/by-nc-nd/2.5/ar/  
dc.subject
ARGENTINA  
dc.subject
COST-UTILITY ANALYSIS  
dc.subject
DENGUE  
dc.subject
DENGUE VACCINES  
dc.subject.classification
Ciencias y Servicios de Cuidado de la Salud  
dc.subject.classification
Ciencias de la Salud  
dc.subject.classification
CIENCIAS MÉDICAS Y DE LA SALUD  
dc.subject.classification
Salud Pública y Medioambiental  
dc.subject.classification
Ciencias de la Salud  
dc.subject.classification
CIENCIAS MÉDICAS Y DE LA SALUD  
dc.subject.classification
Medicina Tropical  
dc.subject.classification
Ciencias de la Salud  
dc.subject.classification
CIENCIAS MÉDICAS Y DE LA SALUD  
dc.title
Cost-utility analysis of dengue vaccination in a country with heterogeneous risk of dengue transmission  
dc.type
info:eu-repo/semantics/article  
dc.type
info:ar-repo/semantics/artículo  
dc.type
info:eu-repo/semantics/publishedVersion  
dc.date.updated
2020-05-11T13:52:20Z  
dc.journal.volume
34  
dc.journal.number
5  
dc.journal.pagination
616-621  
dc.journal.pais
Países Bajos  
dc.journal.ciudad
Amsterdam  
dc.description.fil
Fil: Orellano, Pablo Wenceslao. Universidad Tecnológica Nacional. Facultad Regional San Nicolás; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Nordeste; Argentina  
dc.description.fil
Fil: Reynoso, Julieta Itati. Gobierno de la Provincia de Buenos Aires. Hospital Interzonal General de Agudos San Felipe de San Nicolás; Argentina  
dc.description.fil
Fil: Stahl, Hans Christian. University Hospital Heidelberg; Alemania  
dc.description.fil
Fil: Salomón, Oscar Daniel. Ministerio de Salud. Instituto Nacional de Medicina Tropical; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Nordeste; Argentina  
dc.journal.title
Vaccine  
dc.relation.alternativeid
info:eu-repo/semantics/altIdentifier/url/https://www.sciencedirect.com/science/article/pii/S0264410X1501837X  
dc.relation.alternativeid
info:eu-repo/semantics/altIdentifier/doi/http://dx.doi.org/10.1016/j.vaccine.2015.12.040